Abstract
In the last 2 years (1989-1990) we have treated a total of 53 patients with metastatic nonseminomatous germ cell tumours (teratoma). In ten cases surgery to remove residual abdominal masses was required on completion of chemotherapy and normalisation of tumour markers (HCG and AFP). In a further three patients with large intra-abdominal masses and little or no other sites of disease surgery was performed as a therapeutic intervention, in the context of plateauing or rising tumour markers despite intensive chemotherapy. In all three, this approach resulted in a rapid fall in tumour markers, and following further chemotherapy all three remain disease free at 7, 12 and 25 months. For this small sub-group of patient failing to respond to chemotherapy who have resectable lesions, interventional surgery should be considered as part of a combined approach to treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
- Einhorn L. H., Williams S. D., Mandelbaum I., Donohue J. P. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer. 1981 Aug 15;48(4):904–908. doi: 10.1002/1097-0142(19810815)48:4<904::aid-cncr2820480407>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- Javadpour N., Ozols R. F., Anderson T., Barlock A. B., Wesley R., Young R. C. A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features. Cancer. 1982 Nov 15;50(10):2004–2010. doi: 10.1002/1097-0142(19821115)50:10<2004::aid-cncr2820501005>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
- Lewis C. R., Fossà S. D., Mead G., ten Bokkel Huinink W., Harding M. J., Mill L., Paul J., Jones W. G., Rodenburg C. J., Cantwell B. BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours. Ann Oncol. 1991 Mar;2(3):203–211. doi: 10.1093/oxfordjournals.annonc.a057906. [DOI] [PubMed] [Google Scholar]
- Loehrer P. J., Sr, Williams S. D., Einhorn L. H. Testicular cancer: the quest continues. J Natl Cancer Inst. 1988 Nov 2;80(17):1373–1382. doi: 10.1093/jnci/80.17.1373. [DOI] [PubMed] [Google Scholar]
- Logothetis C. J., Samuels M. L., Selig D. E., Ogden S., Dexeus F., Swanson D., Johnson D., von Eschenbach A. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med. 1986 Aug;81(2):219–228. doi: 10.1016/0002-9343(86)90255-x. [DOI] [PubMed] [Google Scholar]
- Pizzocaro G., Piva L., Salvioni R., Zanoni F., Milani A. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer. Cancer. 1985 Nov 15;56(10):2411–2415. doi: 10.1002/1097-0142(19851115)56:10<2411::aid-cncr2820561012>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- van der Gaast A., Hoekstra J. W., Croles J. J., Splinter T. A. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. J Urol. 1991 Apr;145(4):829–831. doi: 10.1016/s0022-5347(17)38465-3. [DOI] [PubMed] [Google Scholar]